CCL5 as an adjuvant for cancer immunotherapy

Bibliography

• Schall TJ, Jongstra J, Dyer BJ, A human T cell-specific molecule is a member of a new gene family. J Immunol 1988;141(3):1018-25
   PubMed Web of Science ®Google Scholar
• Danoff TM, Lalley PA, Chang YS, Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. J Immunol 1994;152(3):1182-9
   PubMed Web of Science ®Google Scholar
• Von Luettichau I, Nelson PJ, Pattison JM, RANTES chemokine expression in diseased and normal human tissues. Cytokine 1996;8(1):89-98
   PubMed Web of Science ®Google Scholar
• Nelson PJ, Kim HT, Manning WC, Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993;151(5):2601-12
   PubMed Web of Science ®Google Scholar
• Devergne O, Marfaing-Koka A, Schall TJ, Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179(5):1689-94
   PubMed Web of Science ®Google Scholar
• Wang JH, Devalia JL, Xia C, Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996;14(1):27-35
   PubMed Web of Science ®Google Scholar
• Zhou LJ, Tedder TF. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 1995;86(9):3295-301
   PubMed Web of Science ®Google Scholar
• Sallusto F, Palermo B, Lenig D, Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999;29(5):1617-25
   PubMed Web of Science ®Google Scholar
• Alam R, Stafford S, Forsythe P, RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150(8 Pt 1):3442-8
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Krieger M, Brunner T, RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993;23(3):761-7
   PubMed Web of Science ®Google Scholar
• Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347(6294):669-71
   PubMed Web of Science ®Google Scholar
• Pietrzak A, Misiak-Tloczek A, Brzezinska-Blaszczyk E. Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol Lett 2009;123(1):46-51
   PubMed Web of Science ®Google Scholar
• Sallusto F, Schaerli P, Loetscher P, Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998;28(9):2760-9
   PubMed Web of Science ®Google Scholar
• Lin CL, Suri RM, Rahdon RA, Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur J Immunol 1998;28(12):4114-22
   PubMed Web of Science ®Google Scholar
• Chensue SW, Warmington KS, Allenspach EJ, Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 1999;163(1):165-73
   PubMed Web of Science ®Google Scholar
• Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol 2001;2(2):102-7
   PubMed Web of Science ®Google Scholar
• Zou W, Borvak J, Marches F, Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12. J Immunol 2000;165(8):4388-96
   PubMed Web of Science ®Google Scholar
• Zhang RX, Yu SQ, Jiang JZ, Liu GJ. Complementary DNA microarray analysis of chemokines and their receptors in allergic rhinitis. J Investig Allergol Clin Immunol 2007;17(5):329-36
   PubMed Web of Science ®Google Scholar
• Fuentes-Beltran A, Montes-Vizuet R, Valencia-Maqueda E, Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients. Clin Exp Allergy 2009;39(4):491-9
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Kowalski ML, Grzegorczyk J, RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Mediators Inflamm 2005;2005(6):343-8
   PubMed Web of Science ®Google Scholar
• McCormack G, Moriarty D, O'Donoghue DP, Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001;50(10):491-5
   PubMed Web of Science ®Google Scholar
• Kuna P, Alam R, Ruta U, Gorski P. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am J Respir Crit Care Med 1998;157(3 Pt 1):873-9
   PubMed Web of Science ®Google Scholar
• Kameyoshi Y, Dorschner A, Mallet AI, Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992;176(2):587-92
   PubMed Web of Science ®Google Scholar
• Conti P, Pang X, Boucher W, RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites. J Pathol 1997;183(3):352-8
   PubMed Web of Science ®Google Scholar
• Aravindaram K, Yu HH, Lan CW, Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma. Gene Ther 2009;16(11):1329-39
   PubMed Web of Science ®Google Scholar
• Nakazaki Y, Hase H, Inoue H, Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses. Mol Ther 2006;14(4):599-606
   PubMed Web of Science ®Google Scholar
• Song S, Liu C, Wang J, Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect. Vaccine 2009;27(7):1111-8
   PubMed Web of Science ®Google Scholar
• Inoue H, Iga M, Xin M, TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model. Cancer Immunol Immunother 2008;57(9):1399-411
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187(6):875-83
   PubMed Web of Science ®Google Scholar
• Campbell JJ, Qin S, Unutmaz D, Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001;166(11):6477-82
   PubMed Web of Science ®Google Scholar
• Lavergne E, Combadiere C, Iga M, Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Immunol 2004;173(6):3755-62
   PubMed Web of Science ®Google Scholar
• Mule JJ, Custer M, Averbook B, RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum Gene Ther 1996;7(13):1545-53
   PubMed Web of Science ®Google Scholar
• Kutubuddin M, Federoff HJ, Challita-Eid PM, Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. Blood 1999;93(2):643-54
   PubMed Web of Science ®Google Scholar
• Lapteva N, Aldrich M, Weksberg D, Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity. J Immunother 2009;32(2):145-56
   PubMed Web of Science ®Google Scholar
• Fischer FR, Luo Y, Luo M, RANTES-induced chemokine cascade in dendritic cells. J Immunol 2001;167(3):1637-43
   PubMed Web of Science ®Google Scholar
• Bruserud O, Ryningen A, Olsnes AM, Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 2007;92(3):332-41
   PubMed Web of Science ®Google Scholar
• Olsnes AM, Motorin D, Ryningen A, T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC). Cancer Immunol Immunother 2006;55(7):830-40
   PubMed Web of Science ®Google Scholar
• Mrowietz U, Schwenk U, Maune S, The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 1999;79(7-8):1025-31
   PubMed Web of Science ®Google Scholar
• Burke F, Relf M, Negus R, Balkwill F. A cytokine profile of normal and malignant ovary. Cytokine 1996;8(7):578-85
   PubMed Web of Science ®Google Scholar
• Niwa Y, Akamatsu H, Niwa H, Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 2001;7(2):285-9
   PubMed Web of Science ®Google Scholar
• Luboshits G, Shina S, Kaplan O, Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 1999;59(18):4681-7
   PubMed Web of Science ®Google Scholar
• Vaday GG, Peehl DM, Kadam PA, Lawrence DM. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 2006;66(2):124-34
   PubMed Web of Science ®Google Scholar
• Wilcox RA, Wada DA, Ziesmer SC, Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood 2009;114(14):2936-44
   PubMed Web of Science ®Google Scholar
• Konig JE, Senge T, Allhoff EP, Konig W. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate 2004;58(2):121-9
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yao F, Yao X, Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep 2009;21(4):1113-21
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449(7162):557-63
   PubMed Web of Science ®Google Scholar
• Makinoshima H, Dezawa M. Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway. FEBS Lett 2009;583(22):3697-703
   PubMed Web of Science ®Google Scholar
• Murooka TT, Rahbar R, Fish EN. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation. Biochem Biophys Res Commun 2009;387(2):381-6
   PubMed Web of Science ®Google Scholar
• Manes S, Mira E, Colomer R, CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med 2003;198(9):1381-9
   PubMed Web of Science ®Google Scholar
• Stormes KA, Lemken CA, Lepre JV, Inhibition of metastasis by inhibition of tumor-derived CCL5. Breast Cancer Res Treat 2005;89(2):209-12
   PubMed Web of Science ®Google Scholar
• Jayasinghe MM, Golden JM, Nair P, Tumor-derived CCL5 does not contribute to breast cancer progression. Breast Cancer Res Treat 2008;111(3):511-21
   PubMed Web of Science ®Google Scholar
• Kondo T, Ito F, Nakazawa H, High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. J Urol 2004;171(6 Pt 1):2171-5
   PubMed Web of Science ®Google Scholar
• Bai B, Tanaka K, Tazawa T, Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients. J Dermatol Sci 2005;39(3):189-91
   PubMed Web of Science ®Google Scholar
• Liou JM, Lin JT, Huang SP, RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol 2008;43(2):115-23
   PubMed Web of Science ®Google Scholar
• Robinson SC, Scott KA, Balkwill FR. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 2002;32(2):404-12
   PubMed Web of Science ®Google Scholar
• Gelmini S, Mangoni M, Serio M, The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. J Endocrinol Invest 2008;31(9):809-19
   PubMed Web of Science ®Google Scholar
• Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 2008;267(2):271-85
   PubMed Web of Science ®Google Scholar
• Keibel A, Singh V, Sharma MC. Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des 2009;15(17):1949-55
   PubMed Web of Science ®Google Scholar
• Larmonier N, Marron M, Zeng Y, Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother 2007;56(1):48-59
   PubMed Web of Science ®Google Scholar
• Gao JL, Kuhns DB, Tiffany HL, Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. J Exp Med 1993;177(5):1421-7
   PubMed Web of Science ®Google Scholar
• Su SB, Mukaida N, Wang J, Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes. J Leukoc Biol 1996;60(5):658-66
   PubMed Web of Science ®Google Scholar
• Kitaura M, Nakajima T, Imai T, Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996;271(13):7725-30
   PubMed Web of Science ®Google Scholar
• Ponath PD, Qin S, Post TW, Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996;183(6):2437-48
   PubMed Web of Science ®Google Scholar
• Rubbert A, Combadiere C, Ostrowski M, Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol 1998;160(8):3933-41
   PubMed Web of Science ®Google Scholar
• Gerber BO, Zanni MP, Uguccioni M, Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997;7(11):836-43
   PubMed Web of Science ®Google Scholar
• Uguccioni M, Mackay CR, Ochensberger B, High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997;100(5):1137-43
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Polentarutti N, Luini W, Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. J Immunol 1999;162(1):474-9
   PubMed Web of Science ®Google Scholar
• Power CA, Meyer A, Nemeth K, Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995;270(33):19495-500
   PubMed Web of Science ®Google Scholar
• Guo Z, Jang MH, Otani K, CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol 2008;20(3):307-15
   PubMed Web of Science ®Google Scholar
• Sebastiani S, Allavena P, Albanesi C, Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 2001;166(2):996-1002
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187(1):129-34
   PubMed Web of Science ®Google Scholar
• Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1alpha, MIP-1beta, and RANTES. J Leukoc Biol 1996;60(1):147-52
   PubMed Web of Science ®Google Scholar
• Yang YF, Tomura M, Iwasaki M, IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells. J Clin Immunol 2001;21(2):116-25
   PubMed Web of Science ®Google Scholar
• Raport CJ, Gosling J, Schweickart VL, Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 1996;271(29):17161-6
   PubMed Web of Science ®Google Scholar
• Milliken D, Scotton C, Raju S, Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res 2002;8(4):1108-14
   PubMed Web of Science ®Google Scholar
• Romero JM, Aptsiauri N, Vazquez F, Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma. Tissue Antigens 2006;68(4):303-10
   PubMed Web of Science ®Google Scholar